Skip to content

Immunological effect evaluation of three inactivated enterovirus type 71 vaccines

Immunological effect evaluation of three inactivated enterovirus type 71 vaccines

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026663
Enrollment
Unknown
Registered
2019-10-17
Start date
2019-10-28
Completion date
Unknown
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand, foot and Mouth Disease

Interventions

Three Groups:Three batches EV71 Vaccinations

Sponsors

Chinese Center for Disease Control and Prevention
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
0.5 Years to 2 Years

Inclusion criteria

Inclusion criteria: 1. Healthy children aged 6 to 35 months without a vaccination contraindiction of EV71 vaccine; 2. Children who Live in the local area, with good compliance,and can participate in the entire process.

Exclusion criteria

Exclusion criteria: 1. Children previously vaccinated with EV71 vaccine ; 2. Children previously suffering from hand, foot and mouth disease; 3. Children who have received any vaccine within 2 weeks of enrollment; 4. Those who have been treated with blood products or immunosuppressants within 6 months of enrollment; 5. The Guardian refuses to participate in the research.

Design outcomes

Primary

MeasureTime frame
EV71 neutralizing antibody;

Secondary

MeasureTime frame
incidence of adverse events;

Countries

China

Contacts

Public ContactFeng Zijian

nese Center for Disease Control and Prevention

fengzj@chinacdc.cn+86 010-58900309

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026